190 related articles for article (PubMed ID: 36902664)
1. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database.
Pan X; Liu J; Zhang S; Huang S; Chen L; Shen X; Chen D
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902664
[TBL] [Abstract][Full Text] [Related]
2. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
3. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
4. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
[TBL] [Abstract][Full Text] [Related]
5. Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019).
Huang YW; Zhang Y; Li ZP; Yin XS
Front Immunol; 2023; 14():1235266. PubMed ID: 37936706
[TBL] [Abstract][Full Text] [Related]
6. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
Wu Z; Li H; Liao K; Wang Y
J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
[TBL] [Abstract][Full Text] [Related]
7. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
[TBL] [Abstract][Full Text] [Related]
8. Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study.
Yu Y; Yang D; Wang Q; Li J
Pulm Pharmacol Ther; 2024 Jun; 85():102288. PubMed ID: 38460725
[TBL] [Abstract][Full Text] [Related]
9. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
Shao S; Kang H; Tong Z
BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
[TBL] [Abstract][Full Text] [Related]
11. Association between pre-ICU statin use and ARDS mortality in the MIMIC-IV database: a cohort study.
Mao H; Yu Y; Wang Q; Li H
Front Med (Lausanne); 2023; 10():1328636. PubMed ID: 38188328
[TBL] [Abstract][Full Text] [Related]
12. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Mefford B; Donaldson JC; Bissell BD
Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
[No Abstract] [Full Text] [Related]
13. The role of neuromuscular blockers in ARDS: benefits and risks.
Hraiech S; Forel JM; Papazian L
Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
[TBL] [Abstract][Full Text] [Related]
14. Early prophylactic anticoagulation with heparin alleviates mortality in critically ill patients with sepsis: a retrospective analysis from the MIMIC-IV database.
Zou ZY; Huang JJ; Luan YY; Yang ZJ; Zhou ZP; Zhang JJ; Yao YM; Wu M
Burns Trauma; 2022; 10():tkac029. PubMed ID: 36168402
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
[TBL] [Abstract][Full Text] [Related]
16. Effects of dexmedetomidine administration on outcomes in critically ill patients with acute kidney injury: A propensity score-matching analysis.
Yang A; Yang J; Zhou B; Qian J; Jiang L; Jiang Z; Lu G
Clin Nephrol; 2023 Jul; 100(1):28-36. PubMed ID: 37042275
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
Hua Y; Ou X; Li Q; Zhu T
PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
[TBL] [Abstract][Full Text] [Related]
18. Prolonged use of neuromuscular blocking agents is associated with increased long-term mortality in mechanically ventilated medical ICU patients: a retrospective cohort study.
Lin C; Chao WC; Pai KC; Yang TY; Wu CL; Chan MC
J Intensive Care; 2023 Nov; 11(1):55. PubMed ID: 37978572
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
Torbic H; Krishnan S; Harnegie MP; Duggal A
Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
[TBL] [Abstract][Full Text] [Related]
20. Continuously protracted infusion of cisatracurium besilate in patients with ARDS.
Yuan Z; Pan L; Wang Y; Wang W
Ann Med Surg (Lond); 2022 May; 77():103718. PubMed ID: 35638041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
